Please provide your email address to receive an email when new articles are posted on . Black and Hispanic patients spent more years on dialysis and had delayed graft function vs. white patients.

IgA nephropathy has a complex hereditary pattern. You may not develop it unless you inherit multiple risk genes and also ...

Please provide your email address to receive an email when new articles are posted on . Patients on tolvaptan had an eGFR decline of 1.40 mL/min/1.73 m² per year. Annual rate of eGFR decline in ...

Calico Life Sciences announced on Thursday that the U.S. Food and Drug Administration (FDA) has issued Fast Track Designation ...

The FDA has granted Fast Track designation to ABBV-CLS-628 for the treatment of autosomal dominant polycystic kidney disease.

Calico Life Sciences LLC (Calico), a biotechnology organization focused on aging and age-related diseases and founded by Alphabet Inc. and Arthur D. Levinson, today announced the U.S. Food and Drug ...

Silver Spur Therapeutics (SSTX), a preclinical biotech developing a proprietary nanomedicine platform for targeted drug delivery, today announced it has been named a finalist for the life sciences ...

āshibio, a privately held, clinical-stage biotechnology company developing novel therapeutics for the treatment of bone and connective tissue disorders, today announced an exclusive licensing ...

Autosomal dominant optic atrophy (ADOA), the most common genetic optic neuropathy, is an insidious disease. It often presents slowly during childhood by way of blurry vision, trouble reading or ...

Having PKD increases the risk of brain aneurysms. This is due to several factors, including the genetic aspects of PKD and its effect on blood pressure. Polycystic kidney disease (PKD) is a hereditary ...